Background Patent ductus arteriosus (PDA) is associated with significant morbidity and
mortality in preterm infants. Several non‐pharmacological, pharmacological, and surgical …

Aim Ibuprofen and indomethacin are the preferred drug treatment for patent ductus
arteriosus (PDA) in preterm neonates. The comparative safety and efficacy of paracetamol …

Objective Evaluate predictors of successful PDA closure following acetaminophen treatment.
Study design Retrospective cohort study of≤ 30 weeks GA infants born from 1 January 2013 …

Objective To compare the efficacy of low dose-short course intravenous paracetamol with a
conventional dose regimen for early targeted closure of patent ductus arteriosus (PDA) …

Introduction: Various pharmacological treatments are available for preterm infants with
patent ductus arteriosus (PDA), but their risks and benefits are controversial. This study …

Background The different management strategies for patent ductus arteriosus (PDA) in
preterm infants are expectant management, surgery, or medical treatment with non‐selective …

Background: Currently, the first line treatment of persistent ductus arteriosus (PDA) is either
indomethacin or ibuprofen. However, the potentially life-threatening side effects associated …

The use of acetaminophen to close a PDA in preterm infants is increasing; however, the
most effective route of administration is not yet known. This network meta-analysis compares …

This was a first-time evaluation that sought to analyze the cost-effectiveness of oral
paracetamol and intravenous (IV) indomethacin as alternatives to ibuprofen for PDA in …

Objective Acetaminophen and indomethacin are used for medical management of a patent
ductus arteriosus. This study compared the efficacy of these agents in ELBW infants. Study …